Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 1
1996 1
1997 6
1998 16
1999 15
2000 19
2001 18
2002 11
2003 5
2004 3
2005 5
2006 6
2007 2
2008 8
2009 9
2010 14
2011 8
2012 14
2013 11
2014 11
2015 6
2016 4
2017 4
2019 3
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

193 results
Results by year
Filters applied: . Clear all
Page 1
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Souglakos J, Boukovinas I, Kakolyris S, Xynogalos S, Ziras N, Athanasiadis A, Androulakis N, Christopoulou A, Vaslamatzis M, Ardavanis A, Emmanouilides C, Bompolaki I, Kourousis C, Makrantonakis P, Christofyllakis C, Athanasiadis E, Kentepozidis N, Karampeazis A, Katopodi U, Anagnosopoulos A, Papadopoulos G, Prinarakis E, Kalisperi A, Mavroudis D, Georgoulias V. Souglakos J, et al. Among authors: kakolyris s. Ann Oncol. 2019 Aug 1;30(8):1304-1310. doi: 10.1093/annonc/mdz193. Ann Oncol. 2019. PMID: 31228203 Free article.
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M, Karaglani M, Balgkouranidou I, Biziota E, Koukaki T, Karamitrousis E, Nena E, Tsamardinos I, Kolios G, Lianidou E, Kakolyris S, Chatzaki E. Panagopoulou M, et al. Among authors: kakolyris s. Oncogene. 2019 May;38(18):3387-3401. doi: 10.1038/s41388-018-0660-y. Epub 2019 Jan 14. Oncogene. 2019. PMID: 30643192
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
Souglakos J, Androulakis N, Syrigos K, Polyzos A, Ziras N, Athanasiadis A, Kakolyris S, Tsousis S, Kouroussis Ch, Vamvakas L, Kalykaki A, Samonis G, Mavroudis D, Georgoulias V. Souglakos J, et al. Among authors: kakolyris s. Br J Cancer. 2006 Mar 27;94(6):798-805. doi: 10.1038/sj.bjc.6603011. Br J Cancer. 2006. PMID: 16508637 Free PMC article. Clinical Trial.
The development of bronchoscopy in China: a national cross-sectional study.
Shi D, Li F, Wang K, Kong C, Huang H, Li Q, Jin F, Hu C, Wang C, Shi H, Hu Z, Dong Y, Ning Y, Tsakiridis K, Sapalidis K, Kosmidis C, Vagionas A, Hohenforst-Schmidt W, Freitag L, Turner JF, Drevelegas K, Perdikouri EI, Kovacevic T, Sarcev T, Zaric B, Petanidis S, Baka S, Boukovinas I, Kakolyris S, Zarogoulidis P, Bai C. Shi D, et al. Among authors: kakolyris s. J Cancer. 2020 Jul 20;11(19):5547-5555. doi: 10.7150/jca.47183. eCollection 2020. J Cancer. 2020. PMID: 32913450 Free PMC article.
Lung cancer and eye metastases.
Lampaki S, Kioumis I, Pitsiou G, Lazaridis G, Syrigos K, Trakada G, Kakolyris S, Zarogoulidis K, Mpoukovinas I, Rapti A, Zarogoulidis P. Lampaki S, et al. Among authors: kakolyris s. Med Hypothesis Discov Innov Ophthalmol. 2014 Summer;3(2):40-4. Med Hypothesis Discov Innov Ophthalmol. 2014. PMID: 25738158 Free PMC article. Review.
Association between SOX17, Wif-1 and RASSF1A promoter methylation status and response to chemotherapy in patients with metastatic gastric cancer.
Karamitrousis E, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, Trypsianis G, Karayiannakis A, Bolanaki H, Chatzaki E, Kolios G, Lianidou E, Lambropoulou M, Kakolyris S. Karamitrousis E, et al. Among authors: kakolyris s. Clin Chem Lab Med. 2020 Sep 1;59(2):e73-e75. doi: 10.1515/cclm-2020-0662. Clin Chem Lab Med. 2020. PMID: 32870805 No abstract available.
Current and future intratumoral targeted treatment for pancreatic cancer.
Zarogoulidis P, Pavlioglou P, Pivert PL, Machairiotis N, Katsikogiannis N, Kougioumtzi I, Tsimogiannis K, Kakolyris S, Courcoutsakis N, Tsiouda T, Sakkas A, Makrantonaki D, Zarogoulidis K. Zarogoulidis P, et al. Among authors: kakolyris s. Ther Deliv. 2014 Aug;5(8):913-26. doi: 10.4155/tde.14.44. Ther Deliv. 2014. PMID: 25337648 Review.
H2AX a promising biomarker for lung cancer: a review.
Matthaios D, Hountis P, Karakitsos P, Bouros D, Kakolyris S. Matthaios D, et al. Among authors: kakolyris s. Cancer Invest. 2013 Nov;31(9):582-99. doi: 10.3109/07357907.2013.849721. Cancer Invest. 2013. PMID: 24164298 Review.
193 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page